Investors / United Kingdom / Empirical Ventures
Empirical Ventures
Venture capital · London, United Kingdom · Europe
Empirical Ventures is a specialist venture capital firm and venture builder that backs early-stage deep-tech and life-science companies spun out of university and research institution research. It leads pre-seed and seed rounds, typically writing initial cheques of £350k to £750k, and also runs a venture studio.
Invests inHealthcare & BiotechIndustrial & Manufacturing
In its own wordsdeep techlife sciencesadvanced materialsroboticsenergytechbio
Your fit with Empirical Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsEmpirical Ventures lists 31 checked portfolio companies on its own site and is named in 15 funding rounds, 6 of them as lead. Its most frequent entry is Seed, 93% of the companies with a known first round. Its largest themes are Healthcare & Biotech (42%), Industrial & Manufacturing (22%) and AI & Machine Learning (13%). 87% of its companies are based in United Kingdom. It invests most often alongside Science Creates Ventures, Creative Destruction Lab and Deeptech Labs.
Counts come from funding rounds that name Empirical Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Empirical Ventures' whole history. Rounds on record name 15 companies; its own site lists 31. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 93% |
| Series A | 7% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 4 | 2 |
| '26 | 11 | 4 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 69th | 31 companies |
| Recent activity | 95th | 10 rounds in 12 months |
| Early stage | 86th | 93% of entries at pre-seed or seed |
| Evidence | 97th | 32% of companies confirmed by a round |
| Sector focus | 76th | 42% in its largest sector |
| Reach | 70th | 4 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 42% | 15% |
| Industrial & Manufacturing | 22% | 7% |
| AI & Machine Learning | 13% | 18% |
| Education | 7% | 7% |
| Robotics & Hardware | 2% | 1% |
| Media & Entertainment | 2% | 4% |
| Enterprise Software | 2% | 8% |
| Space & Defense | 2% | 3% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Science Creates Ventures | 6 |
| Creative Destruction Lab | 5 |
| Deeptech Labs | 3 |
| Future Planet Capital | 3 |
| Northern Gritstone | 3 |
| QantX | 3 |
| The FSE Group | 3 |
| UKI2S | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3097%
- No longer answers00%
- Points to another company13%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Science Creates Ventures
Compare Empirical Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Empirical Ventures| Date | Company | Stage |
|---|---|---|
| 10 Nov 2026 | Seed | |
| 7 Oct 2026 | Seed | |
| 27 Jul 2026 | Seed | |
| 7 Jul 2026 | Seed Led | |
| 30 Jun 2026 | Seed Led | |
| 22 Jun 2026 | Series A | |
| 27 May 2026 | Seed Led | |
| 13 Apr 2026 | Seed Led |
Round details for Empirical Ventures
Amounts, full round histories and every co-investor in Empirical Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
31 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Albotherm develops heat-activated glass materials that transition from clear to reflective white as the temperature rises, for use in various applications such as greenhouses, buildings, and vehicles. | Industrial & ManufacturingReal Estate & Construction | Portfolio page | ||
| Anaphite Limited develops and applies dry coating technology for battery manufacturing. | Industrial & ManufacturingClimate & Energy | Portfolio page | ||
| Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. | Healthcare & Biotech | Portfolio page | ||
| BioTryp develops small molecules that inhibit biofilm formation to treat bacterial infections | Healthcare & Biotech | Portfolio page | ||
| BoobyBiome develops a product that preserves the living microbiome in stored breast milk. | Healthcare & Biotech | Sept 2025Seed | Page + round | |
| CheMastery applies Process Chemistry to seamlessly connect R&D and manufacturing, enabling precise control of chemical processes across both discovery and repetitive synthesis. | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| DiPOLE Systems Ltd develops and deploys world-leading lasers to drive innovation in advanced manufacturing, defence, security and energy | Industrial & ManufacturingAI & Machine Learning | Apr 2026Seed | Portfolio page | |
| EnsiliTech develops a technology to prevent degradation of thermally unstable biomolecules | Healthcare & Biotech | Aug 2025Seed | Page + round | |
| Exciting Instruments develops and provides single-molecule fluorescence technology for life science research, drug development, and clinical diagnostics | Healthcare & Biotech | Portfolio page | ||
| The company creates highly targeted small molecule treatments using leading-edge technologies. | Healthcare & Biotech | Portfolio page | ||
| Healome Therapeutics is an ophthalmology and ocular drug delivery company aiming to improve the safety, effectiveness, and usability of ocular drugs and treatment of ocular surface conditions. | Healthcare & Biotech | Jul 2026Seed | Funding round | |
| Lucida Medical develops AI systems to assist clinicians to detect and diagnose cancer using MRI | Healthcare & Biotech | Portfolio page | ||
| MintNeuro builds semiconductor components for neural devices, including implants and wearables. | Healthcare & BiotechRobotics & Hardware | Oct 2026Seed | Page + round | |
| MitoRx is developing new treatments to restore healthy mitochondrial metabolism in patients living with high-risk obesity. | Healthcare & Biotech | Portfolio page | ||
| Neobe Therapeutics designs programmable microbial trojan horses engineered to disrupt the microenvironment of solid tumours, enabling immunotherapy success in patients with immune excluded tumours. | Healthcare & Biotech | Nov 2026Seed | Funding round | |
| Neuronostics develops digital biomarkers for neurological care, specifically for epilepsy diagnosis using EEG analysis. | Healthcare & Biotech | Jun 2026Seed | Page + round | |
| NexusAM accelerates the adoption of metal additive manufacturing by turning real-time sensor data into quantifiable insights | AI & Machine LearningIndustrial & Manufacturing | Apr 2025Seed | Page + round | |
| Nuclear Turbines designs and develops compact nuclear reactors for electricity generation | EducationIndustrial & Manufacturing | Jul 2026Seed | Page + round | |
| Optera provides enterprise emissions management software | Enterprise SoftwareSpace & Defense | Portfolio page | ||
| Orthofuse designs advanced orthopedic solutions using 3D printing technology | Healthcare & Biotech | Feb 2026Seed | Page + round |
About this data
site last read 11 Nov 2026- Site
- empiricalventures.vc
- Last read
- 11 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 1 Apr 2025
- Companies checked
- 31
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Empirical Ventures' profile as data
Pull Empirical Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/empiricalventures.vc
# also
GET /v1/firms/empiricalventures.vc/portfolio
GET /v1/firms/empiricalventures.vc/coinvestors
GET /v1/firms/empiricalventures.vc/news